Holdings of Royalty Pharma Sub-Manager, LLC
3 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 3 | 147.9M $ | 100.00 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Cytokinetics Inc | 980,392 | 64.6M $ | |
| Bicara Therapeutics Inc | 2,388,150 | 46.7M $ | |
| BioCryst Pharmaceuticals Inc | 3,846,154 | 36.6M $ |